Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 110 (RPL21P110)
- Target
- RPL21P110
- Molecular classification
- Pseudogene, Processed pseudogene
01
Overview
Ribosomal protein L21 pseudogene 110 (RPL21P110) is a human processed pseudogene located on chromosome 13 (genomic position: 13:72,703,692-72,704,138), derived from the gene encoding ribosomal protein L21[4][6][13]. Unlike its parental gene, which encodes a component of the large 60S ribosomal subunit essential for protein synthesis, RPL21P110 is a genomic sequence that resembles RPL21 but is nonfunctional and does not contribute to ribosome structure or cellular processes. Pseudogenes such as RPL21P110 are common throughout the genome, arising through gene duplication or retrotransposition events, and typically do not participate in biological pathways, disease mechanisms, or therapeutic interventions[5][7][13][12].
- Other names
- RPL21_50_1323RPL21P110
02
Mechanism of action
none (no drugs interact with pseudogenes)
03
Biological functions
Other (not applicable; pseudogenes generally lack direct biological functions)
04
Disease associations
Other (no direct disease association; the parental gene RPL21 is linked to specific hair disorders, but the pseudogene is not implicated)
Beyond the preview
Go deeper on Ribosomal protein L21 pseudogene 110 (RPL21P110).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 110 (RPL21P110).